for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
U.S. Regulatory News

U.S. FDA approves Parkinson's treatment from Sunovion Pharma

May 21 (Reuters) - The U.S. Food and Drug Administration on Thursday approved a sublingual film from Sunovion Pharmaceuticals Inc, a unit of Japan-based Sumitomo Dainippon , for the treatment of “off” episodes in patients with Parkinson’s disease, according to a label published by the agency.

Parkinson's disease is a nervous system disorder in which patients suffer from motor fluctuations which oscillate between "off" times, a state of decreased mobility, and "on" times, or periods when the medication is working and symptoms are controlled. (bit.ly/2Xklr2A) (Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up